Chylomicron retention disease: A long term study of two cohorts

Molecular Genetics and Metabolism

Volumn 97, Issue 2, 2009, Pages 136-142

  Peretti, Noel ^a,f   Roy, Claude C ^a   Sassolas, Agnès ^b   Deslandres, Colette ^a   Drouin, Eric ^a   Rasquin, Andrée ^a   Seidman, Ernest ^c   Brochu, Pierre ^a   Vohl, Marie Claude ^d,e   Labarge, Sylvie ^f,g   Bouvier, Raymonde ^f,g   Samson Bouma, Marie Elizabeth ^h   Charcosset, Mathilde ^b   Lachaux, Alain ^f,g   Levy, Emile ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Centre de Biologie Est   (France)

^c MCGILL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITÉ LYON 1   (France)

^g HOSPICES CIVILS DE LYON   (France)

^h INSERM   (France)

Author keywords

Apolipoproteins; Cholesterol; Fatty acid composition; Liposoluble vitamins; Sar1B gene mutations

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ESSENTIAL FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ALPHA TOCOPHEROL DEFICIENCY; ANTHROPOMETRY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE DENSITY; CANADA; CHILD; CHYLOMICRON RETENTION DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; FAILURE TO THRIVE; FEMALE; FOLLOW UP; FRANCE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GROWTH; HUMAN; HUMAN TISSUE; HYPOCHOLESTEROLEMIA; MALE; MEDICAL RECORD; NEUROLOGIC EXAMINATION; OPHTHALMOLOGY; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; STEATORRHEA;

EID: 67349198653     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.02.003     Document Type: Article

References (38)

1. Hussain M.M., Fatma S., Pan X., and Iqbal J. Intestinal lipoprotein assembly. Curr. Opin. Lipidol. 16 (2005) 281-285
2. Levy E., and Bendayan M. Use of immunoelectron microscopy and intestinal models to explore the elaboration of apolipoproteins required for intraenterocyte lipid transport. Microsc. Res. Tech. 49 (2000) 374-382
3. Peretti N., Marcil V., Drouin E., and Levy E. Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency. Nutr. Metab. (Lond.) 2 (2005) 11
4. Young S.G., Hubl S.T., Chappell D.A., Smith R.S., Claiborne F., Snyder S.M., and Terdiman J.F. Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46). N. Engl. J. Med. 320 (1989) 1604-1610
5. Schonfeld G., Lin X., and Yue P. Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol. Life Sci. 62 (2005) 1372-1378
6. Levy E., Roy C.C., Thibault L., Bonin A., Brochu P., and Seidman E.G. Variable expression of familial heterozygous hypobetalipoproteinemia: transient malabsorption during infancy. J. Lipid Res. 35 (1994) 2170-2177
7. Wetterau J.R. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258 (1992) 999-1001
8. Sharp D. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 365 (1993) 65-69
9. Jones B. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat. Genet. 34 (2003) 29-31
10. Anderson C.M., Townley R.R., Freemanm M., and Johansen P. Unusual causes of steatorrhoea in infancy and childhood. Med. J. Aust. 48 2 (1961) 617-622
11. Bouma M.E., Beucler I., Aggerbeck L.P., Infante R., and Schmitz J. Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease. J. Clin. Invest. 78 (1986) 398-410
12. Dannoura A.H., Berriot-Varoqueaux N., Amati P., Abadie V., Verthier N., Schmitz J., Wetterau J.R., Samson-Bouma M.E., and Aggerbeck L.P. Anderson's disease: exclusion of apolipoprotein and intracellular lipid transport genes. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2494-2508
13. Roy C.C. Malabsorption, Hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease. Gastroenterology 92 (1987) 390-399
14. Siddiqi S.A., Gorelick F.S., Mahan J.T., and Mansbach C.M. COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle. J. Cell Sci. 116 (2003) 415-427
15. Barlowe C. COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell 77 (1994) 895-907
16. Barlowe C., and Schekman R. SEC12 encodes a guanine-nucleotide-exchange factor essential for transport vesicle budding from the ER. Nature 365 (1993) 347-349
17. Charcosset M., Sassolas A., Peretti N., Roy C.C., Deslandres C., Sinnett D., Levy E., and Lachaux A. Anderson or chylomicron retention disease: Molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. Mol. Genet. Metab. 93 (2008) 74-84
18. M. Sempé, G. Pédron. Courbes collectives de la croissance somatique (taille, poids, périmètre crânien)-garçons et filles séparément (amplitudes, itinéraires, accroissements), in: Carnet de Santé, Simep-Masson, Theraplix, Merieux, Serono, Méditions, Lyon, 1995.
19. J.H. van de Kamer, H.U.I.N. Ten Bokkel, H.A. Weyers, Rapid method for the determination of fat in feces, J. Biol. Chem. 177 (1949) 347-355.
20. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
21. Lepage G., Levy E., Ronco N., Smith L., Galeano N., and Roy C.C. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J. Lipid Res. 30 (1989) 1483-1490
22. Levy E., Rizwan Y., Thibault L., Lepage G., Brunet S., Bouthillier L., and Seidman E. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am. J. Clin. Nutr. 71 (2000) 807-815
23. van der Sluis I.M., de Ridder I.M.A., Boot A.M., Krenning E.P., and de Muinck Keizer-Schrama S.M. Reference data for bone density and body composition measured with dual energy X-ray absorptiometry in white children and young adults. Arch. Dis. Child 87 (2002) 341-347
24. Lacaille F., Bratos M., Bouma M.E., Jos J., Schmitz J., and Rey J. Anderson's disease. Clinical and morphologic study of 7 cases. Arch. Fr. Pediatr. 46 (1989) 491-498
25. Sokol R.J. Vitamin E and neurologic deficits. Adv. Pediatr. 37 (1990) 119-148
26. Bouma M.E., Infante R., Jos J., and Schmitz J. Chylomicron retention disease. Gastroenterology 94 (1988) 554-556
27. Berriot-Varoqueaux N. Apolipoprotein B48 glycosylation in abetalipoproteinemia and Anderson's disease. Gastroenterology 121 (2001) 1101-1108
28. Stagg S.M., LaPointe P., Razvi A., Gurkan C., Potter C.S., Carragher B., and Balch W.E. Structural basis for cargo regulation of COPII coat assembly. Cell 134 (2008) 474-484
29. Dipple K.M., and McCabe E.R. Modifier genes convert "Simple" Mendelian disorders to complex traits. Mol. Genet. Metab. 71 (2000) 43-50
30. Kuwana T., Peterson P.A., and Karlsson L. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. Proc. Natl. Acad. Sci. USA 95 (1998) 1056-1061
31. Shoulders C.C., Stephens D.J., and Jones B. The intracellular transport of chylomicrons requires the small GTPase, Sar1b. Curr. Opin. Lipidol. 15 (2004) 191-197
32. Ridsdale A., Denis M., Gougeon P.Y., Ngsee J.K., Presley J.F., and Zha X. Cholesterol is required for efficient endoplasmic reticulum-to-Golgi transport of secretory membrane proteins. Mol. Biol. Cell 17 (2006) 1593-1605
33. Gusarova V., Brodsky J.L., and Fisher E.A. Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER. J. Biol. Chem. 278 (2003) 48051-48058
34. Scriver C.R., and Waters P.J. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 15 (1999) 267-272
35. Vockley J., Rinaldo P., Bennett M.J., Matern D., and Vladutiu G.D. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol. Genet. Metab. 71 (2000) 10-18
36. Guilmeau S. Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes. Histochem. Cell Biol. 128 (2007) 115-123
37. Norris A.W., and Spector A.A. Very long chain n-3 and n-6 polyunsaturated fatty acids bind strongly to liver fatty acid-binding protein. J. Lipid Res. 43 (2002) 646-653
38. Innis S.M. Dietary (n - 3) fatty acids and brain development. J. Nutr. 137 (2007) 855-859